Rafael Holdings Appoints Mimi Huizinga, MD, MPH as Chief Development and Medical Officer

/PRNewswire/ -- Rafael Holdings, Inc., (NYSE: RFL), a pharmaceutical holding company focused on developing novel cancer metabolism therapeutics through its...

Related Keywords

Mary Margaret Mimi Huizinga ,Quality At Lifepoint Health ,Professor At Johns Hopkins University ,Lipomedix Pharmaceuticals Ltd ,Rafael Pharmaceuticals ,Health Information ,Rafael Holdings Inc ,Novartis ,Barer Institute ,American College Of Physicians ,Rafael Pharmaceuticals Inc ,Mckinsey Company ,Vanderbilt University ,Rafael Holdings ,Mary Margaret ,Chief Development ,Medical Officer ,Ameet Mallik ,Chief Executive Officer ,Chief Health Information Officer ,Applied Sciences ,Lifepoint Health ,Associate Professor ,Johns Hopkins ,American College ,Lipomedix Pharmaceuticals ,Clear Cell Sarcoma ,Private Securities Litigation Reform Act ,Annual Report ,Nc ,